[D1-A5] Advancing drug development: Comprehensive and optimum approaches to the immunogenicity assessment

6:05 PM - 6:35 PM JST(9:05 AM - 9:35 AM UTC)

[D1-A5-02] Telling the Whole Story: The Integrated Summary of Immunogenicity

*Paul D Chamberlain¹ (1. Immunogenicity Integrated Platform)

Password required to view

Log in

or